Finally a market update other than that which is mandatory.
EBITDA breakeven shifting into the new FY not a problem. IMO, they are gaining traction. Enter the new MD and with continued focus on their 'innovative & disruptive' imaging solution software, we could be well rewarded going forward. Trusting my gut on this one and this update is a positive for me. Definitely a long game and IMO looking very attractive at 17.5 cents.
Each contract win is a further product endorsement. Patents could serve them well going forward.
Rokewa
News: M7T Mach7 Technologies to divest its 3D medical operations, page-3
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add M7T (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $94.08M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 38.0¢ | $33.93K | 87.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 10832 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 47665 | 2 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| M7T (ASX) Chart |